Errani, F., Nai, F., Bochenkova, E., Herok, M., Invernizzi, A., Bedi, R. K., … Caflisch, A. (2026). Structure-Based Design of Potent Pan-YTHDF Ligands. Journal of Medicinal Chemistry. https://doi.org/10.1021/acs.jmedchem.6c02977 (Original work published 2026)

Invernizzi, A., Nai, F., Bedi, R. K., Vargas-Rosales, P. A., Li, Y., Bochenkova, E., … Caflisch, A. (2025). Discovery of YTHDF2 Ligands by Fragment-Based Design. ACS Bio & Med Chem Au, 5(4), 753–765. https://doi.org/10.1021/acsbiomedchemau.5c00099 (Original work published)

Zálešák, F., Nai, F., Herok, M., Bochenkova, E., Bedi, R. K., Li, Y., … Caflisch, A. (2024). Structure-based design of a potent and selective YTHDC1 ligand. Journal of Medicinal Chemistry, 67(11), 9516-9535. https://doi.org/10.1021/acs.jmedchem.4c00599 (Original work published)

Errani, F., Invernizzi, A., Herok, M., Bochenkova, E., Stamm, F., Corbeski, I., … Caflisch, A. (2024). Proteolysis targeting chimera degraders of the METTL3–14 m6A-RNA methyltransferase. Journal of the American Chemical Society Au, 4(2), 713-729. https://doi.org/10.1021/jacsau.4c00040 (Original work published)

Nai, F., Nachawati, R., Zálešák, F., Wang, X., Li, Y., & Caflisch, A. (2022). Fragment ligands of the m6A-RNA reader YTHDF2. ACS Medicinal Chemistry Letters, 13(9), 1500-1509. https://doi.org/https://doi.org/10.1021/acsmedchemlett.2c00303

Li, Y., Bedi, R. K., Nai, F., von Roten, V., Dolbois, A., Zálešák, F., … Caflisch, A. (2022). Structure-based design of ligands of the m6A-RNA reader YTHDC1. European Journal of Medicinal Chemistry Reports, 5, 100057. https://doi.org/https://doi.org/10.1016/j.ejmcr.2022.100057